Clinical Observation on effect of comprehensive immunotherapy in treating hepatic carcinoma after embolization chemotherapy

Wang Huaizhang

doi:10.1007/BF02934652

Your Location：

Home >

Browse articles >

Clinical Observation on effect of comprehensive immunotherapy in treating hepatic carcinoma after embolization chemotherapy

Updated：2021-08-27

- Clinical Observation on effect of comprehensive immunotherapy in treating hepatic carcinoma after embolization chemotherapy
- Chinese Journal of Integrative Medicine Vol. 5, Issue 2, Pages: 101-104(1999)
- Affiliations：
  
  Henan Provincial Tumor Hospital,Zhengzhou
- Author bio：
- Funds：
- DOI：10.1007/BF02934652
  CLC：
- Published：1999，
Scan for full text
Huaizhang, W. Clinical Observation on effect of comprehensive immunotherapy in treating hepatic carcinoma after embolization chemotherapy., CJIM 5, 101–104 (1999). https://doi.org/10.1007/BF02934652

Wang Huaizhang. Clinical Observation on effect of comprehensive immunotherapy in treating hepatic carcinoma after embolization chemotherapy. [J]. Chinese Journal of Integrative Medicine 5(2):101-104(1999)
Huaizhang, W. Clinical Observation on effect of comprehensive immunotherapy in treating hepatic carcinoma after embolization chemotherapy., CJIM 5, 101–104 (1999). https://doi.org/10.1007/BF02934652 DOI：

Wang Huaizhang. Clinical Observation on effect of comprehensive immunotherapy in treating hepatic carcinoma after embolization chemotherapy. [J]. Chinese Journal of Integrative Medicine 5(2):101-104(1999) DOI： 10.1007/BF02934652.

摘要

Objective: To probe the relationship between survival period and immune function of hepatic carcinoma patients after embolization chemotherapy.Methods: One hundred and eight patients of hepatocarcinoma were randomly divided into three groups. Group A was treated by embolization chemotherapy (ECT) alone

immunotherapy and Chinese herbal medicine were given to Group B and C respectively after ECT.Results: The short-term effective rate of Group A

B and C was 61.1%

83.3% and 80.6% respectively

the three-year survival rate 28.6%

39.1% and 47.3%

and the median survival time 11 months

17 months and 15 months respectively. Observation on immune function after treatment showed that patients who received ECT alone had a lower immunity while those who received immunotherapy or Chinese herbal medicine had a strengthened immunity.Conclusion: Survival period of hepatocarcinoma patients is related with their immune function

strengthening patients’ immunity could extend their survival period relatively.

Abstract

immunotherapy and Chinese herbal medicine were given to Group B and C respectively after ECT.Results: The short-term effective rate of Group A

B and C was 61.1%

83.3% and 80.6% respectively

the three-year survival rate 28.6%

39.1% and 47.3%

and the median survival time 11 months

strengthening patients’ immunity could extend their survival period relatively.

关键词

hepatocarcinomaembolization chemotherapyimmune function

Keywords

hepatocarcinomaembolization chemotherapyimmune function

references

1991: 2–12.

1 1990: 63–290.

48 1995; 29(12): 876–877.

1992; 11 (1): 38–41.

1993; 3(2): 113–115.

1995; 15(2): 102–104.

1991; 13(2): 157–158.

FULL TEXT LINK

More>

Views

354

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Carboxymethylpachymaran enhances immunologic function of dendritic cells cultured in two kinds of hepatoma carcinoma cell line’s supernatant via nuclear factor κB/Rel pathway

Fuzheng Yiliu Granule (扶正抑瘤颗粒) inhibits the growth of hepatocellular cancer by regulating immune function and inducing apoptosis in vivo and in vitro

Clinical observation on the endocrinal and immune functions in subjects with yin-deficiency constitution

Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 (当归补血汤1号) in treating patients of non-small cell lung cancer at peri-operational stage

Effect of TCM combined with chemotherapy on immune function and quality of life of patients with non-small cell lung cancer in stage III-IV

Related Author

No data

Related Institution

Dongpu Branch of the First Affiliated Hospital of Jinan University

Heshan People Hospital

Tongrentang Hospital

Nursing Department, Huanghuai University

Medical College, Jinan University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰